During the past decade, Rhode Island Hospital Genetics-Site Number:840053 conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Rhode Island Hospital Genetics-Site Number:840053" are "Cerebroside Lipidosis Syndrome" (1 trials), "Fabry Disease" (1 trials), "Gaucher Disease" (1 trials), "Glucocerebrosidase Deficiency Disease" (1 trials) and "Glucosylceramide Beta-Glucosidase Deficiency Disease" (1 trials). Many other conditions were trialed in "Rhode Island Hospital Genetics-Site Number:840053" in a lesser frequency.

The vast majority of trials in "Rhode Island Hospital Genetics-Site Number:840053" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Rhode Island Hospital Genetics-Site Number:840053". undefined are not yet recruiting, 4 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Rhode Island Hospital Genetics-Site Number:840053, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Rhode Island Hospital Genetics-Site Number:840053, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".